Observation of Acute Cardiopulmonary Effects in Healthy Individuals Performing Cardiopulmonary Exercise Test (CPX) During Whole Body Vibration (WBV)

• Conditions: Acute Cardiopulmonary Effects

• Registration Number: NCT04162054
• Lead Sponsor: Klinikum der Universität Köln

Brief Summary

Observational study to evaluate acute cardiopulmonary effects of oscillatory whole body vibration (WBV) on healthy individuals analysed in non-invasive cardiopulmonary exercise test (CPX).

Detailed Description

Oscillatory whole-body vibration (WBV) is a novel exercise modality, which is performed on a vibrating platform that moves in sinusoidal oscillations, and during which static and dynamic exercises can be performed. Rapid movements of the platform lead to muscle spindle reflexes, which result in reflectory contraction of muscle groups and thus promote gain of muscle strength and power. The most efficient vibration rate enhancing muscle function is assumed to be ∼20 Hz, leading to constant muscle contraction and anaerobic metabolism of the affected muscle fibres. As a consequence, lactate liberation serves as a stimulus for muscle gain.This methodology has been successfully utilised to enhance moving velocity, muscle power and strength in young athletes and chronic obstructive pulmonary disease though not been understood in all details. Therefore this investigation will help to evaluate acute cardiopulmonary effects of whole body vibration (WBV) on healthy individuals analysed in non-invasive cardiopulmonary exercise test (CPX).

Study Timeline

• Study First Submitted: 2019-04-25
• Study First Submitted QC: 2019-11-11
• Study First Posted: 2019-11-14
• Status Verified: 2020-01
• Last Update Submitted: 2020-01-20
• Last Update Posted: 2020-01-23
• Study Start: 2020-03-01
• Primary Completion: 2020-09-30
• Study Completion: 2020-09-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• healthy individuals planning on performing a WBV-Training
• healthy individuals planning on performing a CPX

Exclusion Criteria

• exclusion to perform CPX
• exclusion to perform WBV

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Peak VO2 in mililiter	one day	maximal Oxygen saturation

Secondary Outcome Measures

Name	Time	Method
Nadir Co2 at anaerobic threshold	one day	Nadir Co2 in mmHG
anaerobic threshold (AT)	one day	AT in mililiter

Trial Locations

Locations (1)

Spezialambulanz für pulmonale Hypertonie Uniklinik Köln; 🇩🇪 Köln, NRW, Germany